(Q44398860)

English

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study

scientific article published on 11 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study (English)

1 reference

Europe PubMed Central

2 December 2017

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

Gunnar Hilmar Gislason

3

1 reference

Europe PubMed Central

2 December 2017

Robert Gniadecki

8

1 reference

Europe PubMed Central

2 December 2017

Peter Riis Hansen

11

1 reference

Europe PubMed Central

2 December 2017

object named as

L Skov

2

0 references

Christian Torp-Pedersen

10

object named as

C Torp-Pedersen

1 reference

Europe PubMed Central

2 December 2017

Lars F. Iversen

6

object named as

L Iversen

1 reference

Europe PubMed Central

2 December 2017

author name string

O Ahlehoff

1

1 reference

Europe PubMed Central

2 December 2017

J Lindhardsen

4

1 reference

Europe PubMed Central

2 December 2017

S L Kristensen

5

1 reference

Europe PubMed Central

2 December 2017

S Lasthein

7

1 reference

Europe PubMed Central

2 December 2017

T N Dam

9

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

11 October 2012

1 reference

Europe PubMed Central

2 December 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

2 December 2017

273

1 reference

Europe PubMed Central

2 December 2017

2

1 reference

Europe PubMed Central

2 December 2017

197-204

1 reference

Europe PubMed Central

2 December 2017

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Inflammation in atherosclerosis: from pathophysiology to practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

AJC editor's consensus: psoriasis and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Current and future management of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Validity of stroke diagnoses in a National Register of Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

The risk of stroke in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Methotrexate in atherogenesis and cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Effective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2012.02593.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2012.02593.X

1 reference

Europe PubMed Central

2 December 2017

release_a66j55n4bzbjbo5zsmtnkzlt5q

1 reference

https://api.fatcat.wiki/v0/release/a66j55n4bzbjbo5zsmtnkzlt5q

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44398860&oldid=2020990499"